International Zinc Association Partners With Pharmanova to Save Children in Zambia
21.1.2026 09:00:00 CET | Business Wire | Press release
Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA), has announced a new partnership with leading Zambian pharmaceutical manufacturer Pharmanova Zambia Limited to expand access to life‑saving zinc treatments for children across Zambia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121178091/en/

Life-saving zinc-supplementation and oral rehydration salts kits are proactively distributed to Zambian children through the works of the International Zinc Association, Pharmanova, and the Zambian Ministries of Health and Education.
The collaboration was formally celebrated during a ceremony in Lusaka with the Zambian Ministry of Health, Pharmanova Zambia Limited, and IZA represented by Environment Health & Sustainability Director Dr. Eric Van Genderen.
IZA and Pharmanova have united in an effort to scale up treatment for childhood diarrhea using zinc, an essential micronutrient that strengthens immune systems and reduces the severity and duration of diarrheal disease. The need is urgent: more than 30% of Zambia’s population is zinc‑deficient, leaving children especially vulnerable to diarrhea, pneumonia, and malaria. Globally, 116,000 children are estimated to die from zinc deficiency related issues every year.
Through this partnership, every dollar donated to Zinc Saves Kids will directly support the distribution of Kit Yamoyo, the “Kit of Life,” which includes oral rehydration salts (ORS) and a ten‑day supply of zinc tablets. Zinc and ORS are recommended by the World Health Organization for the treatment of diarrhea. Each kit provides a complete treatment for diarrhea and helps prevent future illness.
“IZA is thrilled to work with Pharmanova to address zinc deficiency, which weakens the immune systems of at‑risk children and leaves them vulnerable to diarrhea, pneumonia, and malaria,” said Dr. Van Genderen. “Zinc is critical to healthy mental and physical development, and this partnership is an important step toward improving child health in Zambia.”
The first tranche of donations already has supplied 50,000 zinc and oral rehydration kits to Zambian children. Distribution is being conducted through the government’s Healthy Learners program, which operates in schools nationwide and focuses on reaching rural and underserved communities.
Pharmanova, established in 1980, developed Kit Yamoyo to combat childhood diarrhea and has previously partnered with agencies including USAID and UNICEF to expand access to essential medicines.
“There is a great need for Kit Yamoyo across Zambia and beyond, so we are pleased to have the opportunity to work with the International Zinc Association, which has a long history of addressing zinc deficiency worldwide,” said Mohammed Umar, CEO of Pharmanova. “We envision a long and fruitful partnership with Zinc Saves Kids.”
Launched in 2010, Zinc Saves Kids works to raise awareness of global zinc deficiency and supports programs focused on supplementation, food fortification, and treatment. The partnership with Pharmanova marks a significant expansion of the initiative’s reach, which has previously raised more than $4 million to provide life-saving research, education, and treatment related to zinc.
About the International Zinc Association
The International Zinc Association (IZA) is the only organization dedicated exclusively to the interests of zinc and its users. As the voice of the global zinc industry, IZA provides global leadership, coordination, and value on strategic issues for the zinc industry, including market development, license to operate, communications, and sustainability.
About Pharmanova Zambia Limited
Pharmanova Zambia Limited has been at the forefront of the Zambian pharmaceutical manufacturing industry since 1980, providing a diverse range of essential products aimed at enhancing health, hygiene, and overall well-being for Zambia and the region. Pharmanova operates three manufacturing sites strategically located in Lusaka, the capital city of Zambia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260121178091/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 08:03:00 CEST | Press release
Round led by SBI Group follows $51 million Series B raise in May 2026, marking ascent as one of the fastest-growing neobanking platforms. Capital will expand Own Network and deepen AI across stablecoin settlement, tokenization, and corridor banking. Fasset now processes more than $40 billion in annualized transaction volume, serving 3 million+ wallets and more than 1,000 enterprises across 125 countries. Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial
Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 07:11:00 CEST | Press release
Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati
Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 01:01:00 CEST | Press release
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review21.8.2026 21:11:00 CEST | Press release
Authorizations add selection of ZYN ULTRA products to PMI U.S.’s growing portfolio of better alternatives for legal-age adults who smoke or use traditional oral tobacco products Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” ZYN ULTRA positions the brand to furth
58% of Consumers Say They Don't Care Whether a Product is a National Brand or Private Label. They Just Buy What They Need21.8.2026 12:00:00 CEST | Press release
New NIQ & World Data Lab report reveals how consumer polarization is redefining value, accelerating private label adoption, and reshaping competition on the shelf As fast-moving consumer goods (FMCG) prices rose 26% globally between 2021 and 2025, consumers have become more deliberate about where they save and where they spend. NielsenIQ (NYSE: NIQ) has released new findings showing that private label is no longer viewed simply as a lower-cost substitute, but as a credible competitor across value, mainstream, and premium segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260819950224/en/ Private label is no longer just a value play. The findings, published in NIQ’s latest report, A Tale of Two Consumers: The Polarized Mindsets Reshaping Global Consumption, created in collaboration with World Data Lab, show how consumer polarization is redefining value and reshaping competition on the shelf. The report also draws on ins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom